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Introduction
The number of ward referrals due to gout has increased.
Gout can result in a prolonged admission. Guidelines
already exist for gout treatment [1].
The aim of the audit is:-
1. To identify preventable factors in admissions/hospi-
tal flares of gout.
2. To estimate length of stay due to gout.
Methods
The notes of 50 consecutive inpatients referred to Rheu-
matology with gout over a 28 month period were
reviewed.
Results
32 (64%) primarily admitted for gout with a median stay of
8 days. 6 of these admissions were due to polyarticular
gout. 18 patients had gout developing during an admission
for another cause. Length of stay was increased in 4 of
these patients by a median of 4.5 days. Of those primarily
admitted with gout, 17 had a past history of gout, of which
13 had either been on or were still taking allopurinol prior
to admission. Of those that developed gout during admis-
sion, 11 had a past history of gout with 4 having been on
or still on allopurinol. All gout flares were treated with
either NSAID (15) or colchicine (35). Of those that had
steroid treatment (13), NSAIDs or colchicine were used
appropriately. 14 had antibiotic treatment for joint swel-
ling, 3 prior to joint aspiration [2]. Of those with a past
history of gout 29, 17 had a history of past allopurinol use
prior to admission, at least 7 had more than one episode
per year, 5 of these 7 had a prior history of allopurinol.
Of 17 patients previously treated with allopurinol, 6 had
discontinued the drug prior to admission. Of those that
had stopped allopurinol, at least 3 had a flare of their gout
within 3 months of stopping. Of those who were on allo-
purinol prior to admission, the dose was only 100 mg.
Discussion
Total estimated number of bed days due to gout over
study period was 349 days. A potential of 28 patient
admissions were preventable. It was estimated that 2
patients could have had admissions/flares prevented if
they had received allopurinol or other uric acid lowering
drug prior to gout admission/flare according to BSR
guidelines. It is estimated 6 patients inappropriately
stopped their allopurinol. A further 11 were on inappro-
priately low doses of allopurinol.
The majority had the acute episode treated
appropriately.
Conclusion
At least 19 (38%) gout flares out of the total 50 patients
reviewed were preventable, with a maximum potential
of 28 (56%) flares being preventable.
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